United States v. Star Scientific, Inc.

205 F. Supp. 2d 482, 2002 U.S. Dist. LEXIS 10652, 2002 WL 1299872
CourtDistrict Court, D. Maryland
DecidedJune 3, 2002
Docket1:02-cv-00971
StatusPublished
Cited by17 cases

This text of 205 F. Supp. 2d 482 (United States v. Star Scientific, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Star Scientific, Inc., 205 F. Supp. 2d 482, 2002 U.S. Dist. LEXIS 10652, 2002 WL 1299872 (D. Md. 2002).

Opinion

MEMORANDUM

MOTZ, District Judge.

The Plaintiff, the United States of America, has moved to compel Star Scientific, Inc. to comply with a subpoena duces tecum issued from this .Court pursuant to Fed.R.Civ.P. 45. The subpoena requires Star to produce documents in connection with a lawsuit the United States has filed against tobacco companies in the United States District Court for the District of Columbia. See United States v. Philip Morris, Inc., No. 99-CV-02496 (D.D.C. filed Sept. 22, 1999). Star is not a party to that underlying suit. For the reasons set forth below, the motion will be transferred *483 to the United States District Court for the District of Columbia.

I.

Star describes itself as a small and relatively new tobacco company “with a central focus on the reduction of toxins in tobacco and tobacco smoke.” (Def.’s Opp’n at 1.) On November 30, 2001, the United States served Star with a subpoena issued from this Court. The subpoena requested documents that the government asserted were relevant to the Philip Morris case, in which the government alleges a long-running conspiracy by tobacco companies to conceal the dangers of smoking from the public. Among the alleged co-conspirators being sued by the government is Brown & Williamson Tobacco Corp. (“B & W”), a business partner of Star’s. 1

Beginning in the late 1990s, Star contracted to supply B & W with tobacco containing low levels of tobacco specific nitrosamines (“TSNAs”). (See Pokusa Dec. ¶4.) TSNAs are believed by some scientists to be a significant carcinogen in tobacco leaf and cigarette smoke. (See Def.’s Opp’n at 2.) Star believes that “tobacco with lower TSNA levels may eventually be shown to reduce the health risks associated with tobacco use....” (Id.) Star also worked with B & W on the development of Advance, a low-TSNA cigarette that B & W sells pursuant to a royalty agreement with Star, and Ariva, a tobacco lozenge. (See PL’s Mem.Ex. O, Star 2001 Annual Report; Pl.’s Mem. at 13.) The government’s subpoena seeks, inter alia, documents relating to Star’s relationship with B & W.

Star objected to the subpoena, which had requested documents in 13 separate categories. (See id. Ex. A, Subpoena.) As a result, attorneys for Star and the United States met, and the United States agreed to trim its request to documents that would be “particularly useful.” (PL’s Mem. at 4.) The government’s request, as modified, seeks documents in 11 categories. These include “documents concerning any position of or statement made by Star Scientific or any Defendant regarding: the health effects of smoking, nicotine, low nitrosamine tobacco ..., low tar/low nicotine cigarettes, marketing of tobacco products to youth, or FDA regulation of tobacco products” and communications between Star or its Science Advisory Board and defendants about any of these topics. (Id. Ex. F, Ltr. from Jer-rob Duffy & Hima Vatti to Richard McMillan, Jr., Feb. 21, 2002.) The government also seeks contracts between Star and B & W; documents relating to research, development, and marketing by B & W of products containing Star tobacco; documents concerning business contacts Star has had with any defendants other than B & W; and communications by Star about the underlying litigation in this case and an earlier settlement between the states and tobacco manufacturers. (See id.) In addition, the government has requested documents relating to sales of products made or marketed by Star or containing Star tobacco to people under the age of 20, and cost, research, and consumer preference information pertaining to low-TSNA tobacco in general. (See id.)

Star has refused to comply with the modified request. It told the government it would produce only four categories of documents: public statements it has made to health organizations, its press releases on low-TSNA tobacco or tobacco products, *484 its public filings, and copies of warning labels and “onserts,” a type of external package label, for Ariva and the version of Advance that Star test-marketed. (See id. Ex. I, Ltr. from Jonathan H. Pittman to Jerrob Duffy & Hima Vatti, March 15, 2002.)

The United States argues in this motion to compel that Star’s compliance with its modified request is important because Star may possess documents that shed important light on how the defendant tobacco companies viewed smoking and health issues. (See Pl.’s Reply at 2.) Indeed, the government argues that Star is a “probable lynchpin for the continuation of actions by Defendants to maintain the pillars of [their] conspiracy.... ” (Id. at 4.)

Star counters that the subpoena, even as limited by the government, is too sweeping, embracing tens of thousands of pages of documents — -“a majority of the documents in Star Scientific’s possession” — and requiring more than 100 hours of time for its officials and outside counsel to review. (Pokusa Dec. ¶¶ 6-7.) Star also questions the protection that would be afforded to the trade secrets and other sensitive information that it contends are in the documents, despite the issuance by the United States District Court for the District of Columbia of a protective order in the underlying case. (See Pl.’s Mem.Ex. A, Order # 7).

II.

Federal Rule of Civil Procedure 45 establishes the rules for subpoenas served upon individuals and entities that are not parties to the underlying lawsuit. See also Fed.R.Civ.P. 34(c) (“A person not a party to the action may be compelled to produce documents ... as provided in Rule 45.”) When a nonparty receives a subpoena to which it objects, it has several options: file a motion to quash or modify the subpoena pursuant to Fed.R.Civ.P. 45(c)(3)(A), seek a protective order pursuant to Fed. R.Civ.P. 26(c), or, as Star has done here, object to production of documents by opposing a motion to compel under Fed. R.Civ.P. 45(c)(2)(B). 2 See, e.g., Micro Motion, Inc. v. Kane Steel Co., Inc., 894 F.2d 1318, 1322-23 (Fed.Cir.1990) (outlining options).

Rule 45 states that when a person or entity objects to a subpoena served on it, “the party serving the subpoena shall not be entitled to inspect and copy the materials or inspect the premises except pursuant to an order of the court by which the subpoena was issued.”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Untitled Case
D. Maryland, 2026
Harris v. TransAmerica
E.D. North Carolina, 2025
Moore v. Barnes
E.D. North Carolina, 2024
Hartnett v. Hardenbergh
E.D. Virginia, 2024
Gonzalez-Rodriguez v. Gracia
E.D. North Carolina, 2023
Long v. City of Concord
E.D. North Carolina, 2022
Nallapaty v. Nallapati
E.D. North Carolina, 2022
Revak v. Miller
E.D. North Carolina, 2020
Gordon v. Borigini
297 F.R.D. 1 (District of Columbia, 2013)
Maxtena, Inc. v. Marks
289 F.R.D. 427 (D. Maryland, 2012)
Kuznyetsov v. West Penn Allegheny Health Sys.
788 F. Supp. 2d 444 (D. Maryland, 2011)
In Re Subpoena of American Nurses Association
788 F. Supp. 2d 444 (D. Maryland, 2011)
United States v. Philip Morris USA Inc.
566 F.3d 1095 (D.C. Circuit, 2009)
Schaaf v. Smithkline Beecham Corp.
233 F.R.D. 451 (E.D. North Carolina, 2005)
Highland Tank & Mfg. Co. v. PS International, Inc.
227 F.R.D. 374 (W.D. Pennsylvania, 2005)
SmithKline Beecham Corp. v. Synthon Pharmaceuticals Ltd.
210 F.R.D. 163 (M.D. North Carolina, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
205 F. Supp. 2d 482, 2002 U.S. Dist. LEXIS 10652, 2002 WL 1299872, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-star-scientific-inc-mdd-2002.